Position in DNLI
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$357,196
+$356,000 QoQ
Shares Held
18,604
+21040.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amundi holds $2,427,056,148 across 70 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,546,509 | $768,197,412 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,013,540 | $631,982,729 | |
| 3 | RPRX |
Royalty Pharma plc
|
3,723,864 | $208,797,052 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
617,471 | $185,877,294 | |
| 5 | INCY |
Incyte Corp
|
1,181,498 | $133,934,612 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,827,241 | $129,094,576 | |
| 7 | MRNA |
Moderna, Inc.
|
888,779 | $62,241,193 | |
| 8 | ARGX |
Argenx SE
|
65,122 | $60,418,237 |
All Filings in DNLI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $357,196 | 18,604 | Shares | Defined | 2026-05-18 | |
| 2025-03-31 | $1,196 | 88 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,732 | 85 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $92,591 | 3,017 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $97,056 | 3,017 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $134,558 | 3,017 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $152,207 | 3,017 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $236,653 | 3,017 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||